Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Articles en relation
Commentaires
Laissez un commentaire
Tous les champs sont requisPlus de visites
- Le médicament cubain Nimotuzumab, un espoir contre le cancer
- Le ministre cubain des Affaires étrangères qualifie de succès le premier Forum cubain d'affaires sur les TIC (+Photo)
- Bruno Rodríguez félicite le nouveau ministre des Affaires étrangères du Japon pour sa récente nomination
- Cuba commémore la chute au combat de Che Guevara en Bolivie
- Le G77 et la Chine exigent l'exclusion de Cuba de la liste des pays terroristes